MoonLake ImmunotherapeuticsNASDAQ:MLTX
- LAST PRICE48.8300
- TODAY'S CHANGE (%)-3.6700 (-6.9905%)
- Bid / Lots38.0000/ 2
- Ask / Lots66.0000/ 3
- Open / Previous Close51.9800 / 52.5000
- Day Range
- 52 Week Range
- Volume412,764
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MLTX |
|---|---|---|
| 09:32 ET | 2769 | 52.24 |
| 09:35 ET | 200 | 51.5 |
| 09:37 ET | 566 | 51.5 |
| 09:42 ET | 100 | 51.33 |
| 10:00 ET | 500 | 50.85 |
| 10:02 ET | 300 | 50.28 |
| 10:08 ET | 201 | 50.39 |
| 10:09 ET | 1000 | 50.21 |
| 10:11 ET | 2744 | 50.045 |
| 10:13 ET | 800 | 50.025 |
| 10:15 ET | 1407 | 50.26 |
| 10:20 ET | 4834 | 50 |
| 10:22 ET | 900 | 49.97 |
| 10:24 ET | 400 | 50.11 |
| 10:26 ET | 6350 | 49.91 |
| 10:27 ET | 600 | 49.83 |
| 10:29 ET | 1560 | 49.745 |
| 10:31 ET | 4555 | 49.6875 |
| 10:33 ET | 6900 | 49.61 |
| 10:36 ET | 2040 | 49.63 |
| 10:38 ET | 1125 | 49.69 |
| 10:40 ET | 835 | 49.81 |
| 10:42 ET | 6637 | 49.8 |
| 10:44 ET | 400 | 49.77 |
| 10:49 ET | 100 | 49.75 |
| 10:51 ET | 300 | 49.78 |
| 10:54 ET | 2700 | 49.59 |
| 10:56 ET | 500 | 49.765 |
| 10:58 ET | 2500 | 49.46 |
| 11:00 ET | 100 | 49.26 |
| 11:02 ET | 100 | 49.21 |
| 11:03 ET | 400 | 49.21 |
| 11:05 ET | 1305 | 49.225 |
| 11:07 ET | 200 | 49.31 |
| 11:09 ET | 500 | 49.36 |
| 11:16 ET | 1293 | 49.54 |
| 11:18 ET | 1900 | 49.6 |
| 11:20 ET | 400 | 49.53 |
| 11:23 ET | 4548 | 49.645 |
| 11:27 ET | 100 | 49.645 |
| 11:30 ET | 4246 | 49.64 |
| 11:32 ET | 100 | 49.635 |
| 11:34 ET | 2071 | 49.53 |
| 11:36 ET | 760 | 49.3 |
| 11:38 ET | 200 | 49.4615 |
| 11:39 ET | 4305 | 49.75 |
| 11:41 ET | 100 | 49.75 |
| 11:43 ET | 2007 | 49.715 |
| 11:45 ET | 400 | 49.75 |
| 11:48 ET | 600 | 49.64 |
| 11:54 ET | 1215 | 49.8 |
| 11:56 ET | 1771 | 49.77 |
| 11:57 ET | 3680 | 49.64 |
| 12:01 ET | 100 | 49.55 |
| 12:06 ET | 1100 | 49.53 |
| 12:08 ET | 1900 | 49.29 |
| 12:12 ET | 504 | 49.21 |
| 12:14 ET | 5811 | 49.6 |
| 12:15 ET | 7580 | 49.505 |
| 12:17 ET | 2907 | 49.585 |
| 12:19 ET | 200 | 49.6 |
| 12:21 ET | 1242 | 49.3721 |
| 12:26 ET | 1200 | 49.115 |
| 12:28 ET | 1258 | 49.34 |
| 12:30 ET | 1942 | 49.43 |
| 12:32 ET | 24649 | 49.29 |
| 12:33 ET | 400 | 49.24 |
| 12:35 ET | 200 | 49.26 |
| 12:42 ET | 600 | 49.29 |
| 12:44 ET | 300 | 49.335 |
| 12:48 ET | 1300 | 49.49 |
| 12:50 ET | 5569 | 49.84 |
| 12:51 ET | 100 | 49.83 |
| 12:53 ET | 1200 | 49.6 |
| 12:57 ET | 100 | 49.51 |
| 01:00 ET | 1400 | 49.22 |
| 01:02 ET | 101 | 49.31 |
| 01:04 ET | 3826 | 49.55 |
| 01:06 ET | 200 | 49.62 |
| 01:08 ET | 600 | 49.74 |
| 01:09 ET | 100 | 49.73 |
| 01:11 ET | 200 | 49.74 |
| 01:13 ET | 2766 | 49.56 |
| 01:18 ET | 100 | 49.535 |
| 01:20 ET | 100 | 49.58 |
| 01:22 ET | 100 | 49.59 |
| 01:24 ET | 592 | 49.725 |
| 01:26 ET | 800 | 49.52 |
| 01:27 ET | 100 | 49.51 |
| 01:31 ET | 1144 | 49.63 |
| 01:33 ET | 1100 | 49.76 |
| 01:36 ET | 901 | 49.56 |
| 01:38 ET | 300 | 49.47 |
| 01:42 ET | 200 | 49.575 |
| 01:45 ET | 300 | 49.58 |
| 01:47 ET | 1933 | 49.4 |
| 01:54 ET | 100 | 49.14 |
| 01:58 ET | 1500 | 48.99 |
| 02:00 ET | 310 | 48.99 |
| 02:02 ET | 300 | 49.085 |
| 02:07 ET | 152 | 48.9 |
| 02:09 ET | 291 | 48.9 |
| 02:12 ET | 200 | 48.99 |
| 02:14 ET | 300 | 48.92 |
| 02:18 ET | 600 | 48.94 |
| 02:20 ET | 970 | 48.985 |
| 02:21 ET | 500 | 48.985 |
| 02:23 ET | 558 | 48.95 |
| 02:25 ET | 840 | 48.9175 |
| 02:27 ET | 100 | 49.06 |
| 02:30 ET | 504 | 48.85 |
| 02:32 ET | 578 | 48.82 |
| 02:34 ET | 100 | 49 |
| 02:36 ET | 504 | 48.85 |
| 02:38 ET | 500 | 48.84 |
| 02:39 ET | 2100 | 48.82 |
| 02:41 ET | 403 | 48.88 |
| 02:43 ET | 600 | 48.89 |
| 02:45 ET | 100 | 48.82 |
| 03:14 ET | 100 | 48.87 |
| 03:15 ET | 100 | 48.845 |
| 03:17 ET | 887 | 48.63 |
| 03:19 ET | 3573 | 48.38 |
| 03:21 ET | 2487 | 48.44 |
| 03:24 ET | 3415 | 48.375 |
| 03:26 ET | 5612 | 48.445 |
| 03:28 ET | 6565 | 48.42 |
| 03:30 ET | 2179 | 48.44 |
| 03:32 ET | 323 | 48.44 |
| 03:33 ET | 2217 | 48.505 |
| 03:37 ET | 300 | 48.505 |
| 03:39 ET | 2489 | 48.6 |
| 03:42 ET | 6740 | 48.57 |
| 03:44 ET | 1000 | 48.65 |
| 03:46 ET | 1400 | 48.73 |
| 03:48 ET | 3190 | 48.745 |
| 03:50 ET | 800 | 48.68 |
| 03:51 ET | 2204 | 48.71 |
| 03:53 ET | 3240 | 48.665 |
| 03:55 ET | 3901 | 48.62 |
| 03:57 ET | 3664 | 48.85 |
| 04:00 ET | 26822 | 48.83 |
Nov 14, 2024
DJ MoonLake Immunotherap Price Target Maintained With a $100.00/Share by HC Wainwright & Co., from 7:00AM ET on Thursday Nov 14, 2024 by Dow Jones
7:00AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody(R) sonelokimab in patients with active psoriatic arthritis, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 8, 2024
DJ MoonLake Immunotherap Price Target Maintained With a $100.00/Share by HC Wainwright & Co., from 2:29PM ET on Friday Nov 08, 2024 by Dow Jones
2:29PM ET on Friday Nov 08, 2024 by Dow Jones
Nov 7, 2024
MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
DJ MoonLake Immunotherap Coverage Assumed by Wedbush at Outperform, from 4:54AM ET on Tuesday Nov 05, 2024 by Dow Jones
4:54AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MoonLake Immunotherapeutics | 3.1B | -37.8x | --- |
Immunitybio Inc | 3.1B | -5.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.0B | -14.2x | --- |
Edgewise Therapeutics Inc | 2.9B | -21.1x | --- |
Agios Pharmaceuticals Inc | 3.1B | 4.4x | --- |
Company Information
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
Contact Information
- Headquarters
- Dorfstrasse 29ZUG, ZUG, Switzerland 6300
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Simon Sturge
- Chief Executive Officer, Director
- Jorge Santos Da Silva
- Chief Financial Officer
- Matthias Bodenstedt
- Chief Scientific Officer
- Kristian Reich
- Independent Director
- Kara Lassen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 63.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-1.29 |
Book Value | $8.20 |
P/E Ratio | -37.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
